Jardine Matheson to acquire I-MED Radiology Network for $2.4bn
The deal includes I-MED’s stake in Harrison.ai, which develops AI radiology solutions such as CT brain and chest scans.
27 May 2026
27 May 2026
The deal includes I-MED’s stake in Harrison.ai, which develops AI radiology solutions such as CT brain and chest scans.
The CHMP opinion is based on results from the Phase III BREAKWATER trial.
The study involved 35 participants with heterozygous familial hypercholesterolaemia or premature coronary artery disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.